Image pharmaphorum Editor Sales & Marketing Sponsored Acting on the moments that matter to build a brand All too often pharmaceutical marketing orthodoxy says to focus on just one area – a product’s launch, in the belief that this is the only area that can determine success. Views & Analysis Cost concerns with the new NHS pricing scheme A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly. Events Partner Content 10th Annual RNA Therapeutics Conference 10th Annual RNA Therapeutics Conference Events Partner Content WIRED Health 2019 Inspirational conference mapping the future of health Load more results
Sales & Marketing Sponsored Acting on the moments that matter to build a brand All too often pharmaceutical marketing orthodoxy says to focus on just one area – a product’s launch, in the belief that this is the only area that can determine success.
Views & Analysis Cost concerns with the new NHS pricing scheme A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly.
Events Partner Content 10th Annual RNA Therapeutics Conference 10th Annual RNA Therapeutics Conference
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
